85216-54-2

Upstream product

• 4241-27-4 2-hydroxy-6-methylnicotinonitrile 
• 4241-27-4 1,2-dihydro-6-methyl-2-oxo-3-pyridinecarbonitrile 

Downstream Products

• 26820-34-8 2-chloro-3-cyano-6-methyl-5-nitropyridine 
• 89795-73-3 2-hydroxy-6-methyl-5-nitro-nicotinic acid 
• 1049706-70-8 2-(4-chloro-3-trifluoromethylphenoxy)-6-methyl-5-nitronicotinonitrile 
• 147440-57-1 2-(benzyloxy)-5-amino-6-methylnicotinonitrile 
• 847060-24-6 5-amino-4-bromo-2-chloro-6-methyl-nicotinonitrile 
• 84703-17-3 2,5-dichloro-6-methylpyridine-3-carbonitrile 
• 57183-29-6 5-amino-2-chloro-6-methyl-nicotinonitrile 
• 734469-00-2 2-Methyl-3-amino-5-aminomethyl-pyridin 

Relevant academic research and scientific papers

PYRIDYL COMPOUND SUITABLE FOR THE TREATMENT OF METABOLIC DISORDERS

The description relates to a pyridyl compound of Formula 1 wherein A, B, X, R1, R2, R3, R4, R5, R6, and n are as defined in the specification, in all their isotopic forms, stereoisomeric and tautomeric forms and mixtures thereof in all ratios, their pharmaceutically acceptable salts, N-oxides, pharmaceutically acceptable solvates, isosteres and prodrugs thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. The description also relates to a process for the manufacture of the pyridyl compound and a pharmaceutical composition containing the pyridyl compound.

NOVEL MICROBIOCIDES

Compounds of the formula (I) in which the substituents are as defined in claim 1 are suitable for use as microbiocides.